Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.
| Website | https://www.cingulate.com/ |
| Employees | 24 (0 on RocketReach) |
| Founded | 2012 |
| Address | 1901 W. 47th Place Suite 310, Kansas City, Kansas 66205, US |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Next Generation, Biopharmaceutical, Delivery Platform, Drug Delivery, Pharmaceutical Products, Drug Development, Pipeline, Therapeutics, Patient Care, Clinical Trials, Drug Formulation, Biotechnology, Healthcare, Pharma, Medicine, Treatment, Technology, Innovation, Research |
| Competitors | Hinge Health, Iovance Biotherapeutics, Inc., Intra-Cellular Therapies, Sage Therapeutics, 大塚製薬（株）, Cerevel Therapeutics, Akili, MindMed, Axovant Sciences Ltd, Mindstrong Health +37 more (view full list) |
Looking for a particular Cingulate Inc. employee's phone or email?
Cingulate Inc. Questions
Cingulate Inc. is based in Kansas City, Kansas.
